Peking University International Hospital to Establish State-of-the-Art ZAP-X Radiosurgery Center

Prestigious institution partners with Qingdao Baheal Medical Inc. to advance non-invasive treatment for brain tumors and other cranial conditions
The photo shows a formal signing ceremony between Peking University International Hospital and Baheal Medical. Two representatives sit at the table in front, each holding a red folder marked “签约本” (signing document), while several other executives and medical professionals stand behind them, smiling and applauding. The background banner features both institutions’ logos and reads, “Strategic Cooperation Signing Ceremony between Peking University International Hospital and Baheal Medical.” The setting appears professional and celebratory, with flower arrangements and documents placed neatly on the conference table.
Participants at the October 23, 2025 signing ceremony, including Liu Xiaoguang, Deputy Director of Peking University Health Science Center and President of Peking University International Hospital; Fu Gang, Chairman of Baheal Medical; and other senior officials.

San Carlos, Calif. – October 28, 2025 – ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Peking University International Hospital and Baheal Medical have entered into a strategic cooperation agreement to jointly establish a precision radiotherapy center equipped with the ZAP-X® Gyroscopic Radiosurgery® platform. The new center, to be housed at Peking University International Hospital, will deliver the world’s most advanced radiosurgery for brain tumors and other cranial disorders.

Since forging a strategic partnership with ZAP Surgical last year, Baheal Medical has been actively driving the clinical implementation and local production of the ZAP-X in China.

Peking University International Hospital, the Eighth Clinical Medical School of Peking University, is the first Beijing-based training base for the China Anti-Cancer Association integrating clinical care, prevention and screening, and rehabilitation. Beyond patient care, the new precision radiotherapy center will provide training and research opportunities for physicians across China and in countries along the Belt and Road Initiative, further strengthening global collaboration.

Stereotactic radiosurgery (SRS), a completely non-invasive and painless procedure, has emerged as a game-changing treatment for many primary and metastatic brain tumors, as well as other disorders of the head and neck. Typically performed in a single outpatient session, SRS involves no incision, no anesthesia, and no pain, often allowing patients to quickly resume normal activities.

With 20%–40% of all patients diagnosed with a primary cancer developing a secondary cancer in the brain, the annual incidence in China alone exceeds 1.5 million cases. Traditional open surgery often risks secondary complications such as neurological damage or cerebral edema, while most drug therapies are hindered by the blood-brain barrier. As cancer therapies extend patient survival, the incidence of brain metastases continues to rise – driving demand for advanced, non-invasive treatment options.

The ZAP-X system represents the most advanced technology in the field of radiosurgery. Its unique gyroscopic mobility enables delivery of radiosurgical beams from thousands of potential angles, improving precision while helping to spare critical structures such as the brain stem, eyes, and optic nerves. By minimizing radiation exposure to healthy brain tissue, ZAP-X also aims to better safeguard long-term cognitive function.

 

ALT text:A ZAP-X Gyroscopic Radiosurgery System is displayed in a clinical setting. The compact, self-shielded unit features a large spherical treatment head mounted on a rotating base, surrounded by clean, modern medical equipment and soft lighting. The machine’s design emphasizes precision, safety, and innovation in non-invasive brain tumor treatment.
The ZAP-X Gyroscopic Radiosurgery platform (image courtesty of Hacettepe University Hospital)

ZAP-X further distinguishes itself as the first and only vault-free SRS platform, eliminating the need for costly radiation-shielded treatment rooms. Consequently, for the first time, hospitals can site radiosurgery in high-visibility, more convenient environments. In addition, ZAP-X is the only dedicated cranial radiosurgery system powered by a modern linear accelerator rather than Cobalt-60, thereby removing the significant costs and risks associated with managing live radioactive isotopes.


About ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at www.zapsurgical.com and follow us on LinkedIn.

Contact:
Mark Arnold, ZAP Surgical Systems, Inc.
Senior Vice President, Marketing
+1 650 492 7797, ext. 101

Recent News